Assay Systems: Testing of Antiviral Drugs in Cell Culture (In Vitro)
Testing for virus-inhibitory activity of chemicals in cell culture has sometimes furnished important leads in the development of antiviral drugs. The shortcomings of this so-called in vitro testing are obvious: substances which lack an effect on the viral replication cycle but, e.g., enhance antibody formation, improve nonspecific resistance, strengthen the interferon systems will not be detected by this method. Likewise, although so far only rarely described, some compounds affecting the viral replication cycle might reveal their antiviral effects only in an animal model, since metabolic activities of the organism, absent in cell culture, are required to convert the drug into its effective form. Most of the time, however, the reverse is true, viz. more compounds do appear active in a cell culture system than will later be found useful in the organism (Buthala, 1965; Eggers, 1977b). I shall refer to this problem in a later section.
KeywordsAntiviral Activity Antiviral Drug Cell Culture System Cell Sheet Antiviral Compound
Unable to display preview. Download preview PDF.
- Bauer, D.J., and Sadler, P.W., 1960, The structure-activity relationships of the antiviral chemotherapeutic activity of isatin β-thiosemicarbazone. Br. J. Pharmac. Chemother. 15:101–110.Google Scholar
- Bucknall, R.A., 1973, The continuing search for antiviral drugs Adv. Pharmacol. Chemotherapy 11:295–319.Google Scholar
- Buthala, D.A., 1965, Experience gained in screening for synthetic antiviral compounds. Ann. N.Y. Acad. Sci. 130:Art. 1, 17–23.Google Scholar
- Eggers, H.J., 1977b, Specific antiviral substances: testing in experimental animals and in “in vitro” systems. In: International Symposium on Experimental Animals and “in vitro” Systems in Medical Microbiology. WHO Collaborating Centre for Collection and Evaluation of Data on Comparative Virology. Munich, pp. 277–282.Google Scholar
- Hartmann, H., Hunsmann, G., and Eckstein, F., 1987, Inhibition of HIV-induced cytopathogeni ci ty in vitro by 3r-azi do-2′,3′-dideoxyguanosine. Lancet 1:115–116.Google Scholar
- Herrmann, E.C.,Jr., 1961, The detection, assay and evaluation of antiviral drugs. Progr. Med. Virol. 3:158–192.Google Scholar
- Herrmann, E.C.,Jr., Gabliks, J., Engle, C., and Perlman, P.L., 1960, Agar diffusion method for detection and bioassay of antiviral antibiotics. roc. Soc. Exp. Biol. Med. 103:625–628.Google Scholar
- Pauwels, R., De Clercq, E., Desmyter, J., Balzarini, J., Goubau, P., Herdewijn, P., Vanderhaeghe, H., and Vandeputte, M., 1987, Sensitive and rapid assay on MT-4 cells for detection of antiviral compounds against the AIDS virus. J. Virol. Meth. in press.Google Scholar
- Tamm, I., and Eggers, H.J., 1963, Unique susceptibility of enteroviruses to inhibition by 2-(03a1-hydroxybenzyl)-benzimidazole and derivatives. 2nd International Symposium of Chemotherapy, H.P. Kuemmerle, P. Preziosi, P. Rentchnick (eds.). S. Karger, Basel, New York, pp. 88–118.Google Scholar
- Wendler, I., Bienzle, U., and Hunsmann, G., 1987, Neutralizing antibodies and the course of HIV induced disease. AIDS Research and Human Retroviruses, in press.Google Scholar